Mylan’s generic version of multiple sclerosis blockbuster Tecfidera “adds new uncertainty” to the Biogen story, Jefferies analyst Michael Yee wrote in a note to clients. (Mylan on YouTube). Share Facebook Twitter LinkedIn Email Print. Despite Biogen’s intense …
See Original Article

(CNN) Sparks erupted from the bottom of a FedEx cargo jet as it made a pre-dawn emergency landing Wednesday at Los Angeles International Airport, officials said. A man who was hurt while leaving the aircraft was taken to a hospital, said airport …
See Original Article

Canoo is the latest electric-vehicle maker to try to grab the brass ring. The California startup agreed to merge with Hennessy Capital Acquisition SPAC, in a deal valuing Canoo at more than $1.8 billion. It is expected to close in the fourth quarter.
See Original Article

Ram now has a 702-hp off-road-focused 1500 pickup called the TRX, or what the company wants you to call the T. rex. It’s powered by the Hellcat supercharged 6.2-liter V-8 and has standard 35-inch tires, Bilstein adaptive dampers, an active transfer case, …
See Original Article

(Reuters) – The U.S. Food and Drug Administration rejected BioMarin Pharmaceutical Inc’s gene therapy for bleeding disorder hemophilia A citing the need for longer-term data, the drugmaker said on Wednesday, potentially pushing any approval out to 2022.
See Original Article